Supplementary Figures from Impaired SARS-CoV-2 Variant Neutralization and CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections